CBUS vs VRTX · rev $4.3M vs P/E 30, rev $12.00B
Cibus Global LLC (CBUS) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Cibus Global LLC (CBUS) is a biotechnology company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported CBUS revenue for 2024-12-31 was $4.3M. Net income was -$282.7M. Revenue was up 134.6% from 2023-12-31 to 2024-12-31. CBUS currently screens at market cap $79.7M.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
CBUS currently screens at market cap $79.7M. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the CBUS and VRTX stock pages for the full models.
Not investment advice.